Latest News & Updates
Breaking News
5 hours ago
Simantini Singh Deo
Other trending news you may like to read
FDA Approves Novo Nordisk’s Once-Daily Wegovy® Pill, The First Oral GLP-1 For Weight Management With Injectable-Level Results
Novo Nordisk receives FDA approval for the first oral Wegovy pill, offering once-daily GLP-1 therapy for obesity management.
Simantini Singh Deo
FDA Approves Amneal & mAbxience’s Two Denosumab Biosimilars For Prolia® & Oziltus™ For XGEVA®, Marking Major U.S. Launch Under $5.3B Market
Amneal and mAbxience receive FDA approval for two denosumab biosimilars, expanding U.S. access to bone health therapies.
Simantini Singh Deo
Curium Delivers First PYLCLARI® (18F-DCFPyL) Doses To Prostate Cancer Patients In Poland, Expanding European Access
Curium delivers first PYLCLARI doses in Poland, strengthening European access to precision diagnostic imaging for prostate cancer.
Simantini Singh Deo
Alvotech Launches Gobivaz®, the World’s First Simponi® Biosimilar, Across Europe In Partnership With Advanz Pharma
Alvotech launches Gobivaz in Europe, marking the first global biosimilar to Simponi, with rollout supported by NHS England.
Simantini Singh Deo
